Patient-reported outcomes with a personalized follow-up program after lung cancer resection: A single-center randomized controlled trial.

Yiqing Luo, Yuna Cheng, Zuodong Song, Hui Chen, Yinping Bo, Haobo Shixing

Registry-linked trialAbstract read

In one paragraph

Article in Asia-Pacific journal of oncology nursing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06483295 (Randomized Controlled Study on Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06483295 narecruitingnot on this map

Randomized Controlled Study on Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform

TypeinterventionalSponsorShanghai Chest HospitalRan2024 to 2026Enrolled216ConditionsLung CancerArmsUsing mobile internet platforms for follow-up management of postoperative symptoms in lung cancer patients.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yiqing LuoDepartment of Oncology Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Yuna ChengDepartment of Oncology Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Zuodong SongDepartment of Oncology Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Hui ChenDepartment of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Yinping BoDepartment of Intensive Care Unit, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Haobo ShixingDepartment of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aims to determine the impact of PROM with a personalized follow-up program on the evaluation of quality of life and self-management for patients after lung cancer resection. Methods: Given a formal power calculation a total of 240 patients with lung cancer. Participants were randomly assigned to either the experimental or the control groups. Patients in the experimental group received a personalized follow-up program of patient-reported outcomes. The control group received only the telephone follow-up. Baseline data (T0) were collected before the intervention (on the day of discharge), and quality of life, self-efficacy, and compliance were measured at 2 weeks (T1), 4 weeks (T2), and 4 months (T3) post-discharge. Results: The difference in quality of life between the experimental and control groups was significant (Wald χ Conclusions: For patients after lung cancer surgery, the program has optimized the evaluation of postoperative quality of life and self-management efficacy. Trial registration: Chinese Clinical Trial Registry (NCT06483295).

Indexed as

Follow-upLung neoplasmPatient-reported outcomePostoperativeQuality of lifeSelf-management efficacy

Identifiers

PMID41625083

DOI10.1016/j.apjon.2025.100844

PMCPMC12859223

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

NCT06483295ClinicalTrials.gov

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.